Concepedia

Teddy Kosoglou

TK

Statistics

Publications

47

Citations

2K

H-Index

25

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

AGCO (United Kingdom)

Christchurch Clinical Studies Trust

Janssen (United States)

Princess Margaret Hospital

Teddy Kosoglou is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1988–2024

47

Publications

47

Disposition of the Selective Cholesterol Absorption Inhibitor Ezetimibe in Healthy Male Subjects

James E. Patrick, Teddy Kosoglou, Kathe Stauber et al. · Drug Metabolism and Disposition · 2002 · 165 citations

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial

Robert W. Finberg, Riin Lanno, David Anderson et al. · The Journal of Infectious Diseases · 2018 · 128 citations · Full text

A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe

Farkad Ezzet, Gopal Krishna, David Wexler et al. · Clinical Therapeutics · 2001 · 119 citations

, , +9

Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep

Christopher J. Charles, Eric A. Espiner, M. Gary Nicholls et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1996 · 105 citations

, , +18

Pharmacodynamics and Pharmacokinetics of Higher-Dose, Double-Bolus Eptifibatide in Percutaneous Coronary Intervention

Ian C. Gilchrist, J.Conor O’Shea, Teddy Kosoglou et al. · Circulation · 2001 · 99 citations · Full text

1–5 of 47